Teva Pharma Clinical Trials

Company details

Status: Public
HQ: 10 Dornierstr., Ulm, Donau, 89079, DE, TEL AVIV
Employees: 126
Programs: 473
Drugs: 447
Patents: 454

Official website ↗ All projects Drug pipeline Patents News & analysis

Recent coverage

Teva's Olan EMA Application Acceptance: Strategic Implications for Pharma Jun 3, 2026
Teva's Once-Monthly Schizophrenia Shot Enters EMA Review, Signaling New Treatment Option Jun 2, 2026

View all news & analysis →

Recent trial activity

8 updates

Latest clinical program signals indexed for Teva Pharma.

Trial registry

641 studies

2023-508230-33-00
TETRALITE-Ib

Phase 1 active other

Influenza

CTIS ↗
2024-515972-11-00
PCV-LITE-I

Phase 1 active other

Pneumococcal infection

CTIS ↗
NCT00030186
CEP-701 60mg

Phase 2 completed small_molecule

Leukemia, Myeloid

CT.gov ↗
NCT00034814
Talampanel

Phase 2 completed small_molecule

Epilepsy

CT.gov ↗
NCT00035503
etiprednol dicloacetate

Phase 2 completed small_molecule

Crohn's Disease

CT.gov ↗
NCT00036296
talampanel

Phase 2 completed small_molecule

Dyskinesias

CT.gov ↗
NCT00040404
CEP-1347 10mg

Phase 3 terminated small_molecule

Parkinson Disease

CT.gov ↗
NCT00054964
Albuterol HFA-BOI

Phase 2 completed small_molecule

Asthma

CT.gov ↗
NCT00062504
Talampanel

Phase 2 terminated small_molecule

Glioblastoma Multiforme

CT.gov ↗
NCT00069758
SDX-105

Phase 2 completed small_molecule

Non-Hodgkin's Lymphoma

CT.gov ↗
NCT00071539
TP-38

Phase 2 completed small_molecule

Recurrent Glioblastoma Multiforme

CT.gov ↗
NCT00071552
Qvar

Approved terminated small_molecule

Asthma

CT.gov ↗
NCT00076349
bendamustine and rituximab

Phase 2 completed small_molecule

Non-Hodgkin's Lymphoma

CT.gov ↗
NCT00078312
CEP-10953 (Armodafinil)

Phase 3 completed small_molecule

Narcolepsy

CT.gov ↗
NCT00078325
Armodafinil 250 mg/day

Phase 3 completed small_molecule

Obstructive Sleep Apnea

CT.gov ↗
NCT00078377
Armodafinil

Phase 3 completed small_molecule

Narcolepsy

CT.gov ↗
NCT00079482
CEP-701

Phase 2 completed small_molecule

Acute Myeloid Leukemia

CT.gov ↗
NCT00079677
Armodafinil 150 mg/day

Phase 3 completed small_molecule

Obstructive Sleep Apnea

CT.gov ↗
NCT00080288
Armodafinil 150 mg/day

Phase 3 completed small_molecule

Excessive Sleepiness

CT.gov ↗
NCT00081601
CEP-701

Phase 2 completed small_molecule

Prostate Cancer

CT.gov ↗
NCT00085774
albuterol aerosol by HFA MDI

Phase 3 completed small_molecule

Exercise-induced Bronchospasm

CT.gov ↗
NCT00094016
Beclomethasone dipropionate

Phase 3 completed small_molecule

Asthma

CT.gov ↗
NCT00104091
TP-38

Phase 2 completed small_molecule

Glioblastoma Multiforme

CT.gov ↗
NCT00104273
Rasagiline

Phase 2 completed small_molecule

Dementia

CT.gov ↗
NCT00105287
OraVescent fentanyl (OVF)

Phase 3 completed small_molecule

Pain

CT.gov ↗
NCT00105937
OraVescent fentanyl citrate

Phase 3 completed small_molecule

Pain

CT.gov ↗
NCT00107796
Modafinil

Phase 3 completed small_molecule

Narcolepsy

CT.gov ↗
NCT00107809
Modafinil

Phase 3 completed small_molecule

Sleep Apnea, Obstructive

CT.gov ↗
NCT00107848
Modafinil

Phase 3 completed small_molecule

Narcolepsy

CT.gov ↗
NCT00109668
beclomethasone dipropionate (QVAR)

Phase 3 completed small_molecule

Asthma

CT.gov ↗
NCT00112411
Bronchodilator

Phase 2 completed small_molecule

Asthma

CT.gov ↗
NCT00114959
Homoharringtonine

Phase 2 terminated small_molecule

Myeloid Leukemia, Chronic

CT.gov ↗
NCT00117260
Seasonale (levonorgestrel and ethinyl estradiol)

Phase 3 terminated small_molecule

Osteopenia

CT.gov ↗
NCT00117273
Seasonale [levonorgestrel (LNG)/ethinyl estradiol (EE)]

Phase 3 completed small_molecule

Healthy

CT.gov ↗
NCT00117468
DR-2011

Phase 3 completed small_molecule

Infertility

CT.gov ↗
NCT00117481
DR-2001a

Phase 2 completed small_molecule

Endometriosis

CT.gov ↗
NCT00139841
Bendamustine HCl

Phase 3 completed small_molecule

Non-Hodgkin's Lymphoma

CT.gov ↗
NCT00151736
Chlorambucil

Phase 2 terminated small_molecule

Chronic Lymphocytic Leukemia

CT.gov ↗
NCT00196313
levonorgestrel/EE 0.15/0.03 and EE 0.01 mg tablets

Phase 3 completed small_molecule

Dysmenorrhea

CT.gov ↗
NCT00196326
DR-1011

Phase 3 completed small_molecule

Contraception

CT.gov ↗
NCT00196339
Cyproterone acetate 5

Phase 2 completed small_molecule

Prostate Cancer

CT.gov ↗
NCT00196352
Levonorgestrel/EE 0.15/0.03 mg and EE 0.01 mg tablets

Phase 3 completed small_molecule

Contraception

CT.gov ↗
NCT00196365
levonorgestrel/EE 0.15/0.03 and EE 0.01 mg tablets

Phase 3 completed small_molecule

Dysmenorrhea

CT.gov ↗
NCT00196378
Synthetic Conjugated estrogens, B

Phase 3 completed small_molecule

Menopause

CT.gov ↗
NCT00196391
DR-2021a

Phase 2 completed small_molecule

Amenorrhea

CT.gov ↗
NCT00196404
DR-3001a

Phase 2 completed small_molecule

Urinary Incontinence

CT.gov ↗
NCT00202982
glatiramer acetate 20 mg

Phase 2 completed small_molecule

Relapse-Remitting Multiple Sclerosis

CT.gov ↗
NCT00202995
Glatiramer Acetate

Approved terminated small_molecule

Relapsing Remitting Multiple Sclerosis

CT.gov ↗
NCT00203021
Glatiramer Acetate

Approved terminated small_molecule

Relapsing Remitting Multiple Sclerosis

CT.gov ↗
NCT00203034
Rasagiline Mesylate

Approved completed small_molecule

Parkinson's Disease

CT.gov ↗
NCT00203047
Glatiramer Acetate

Approved terminated small_molecule

Relapsing Remitting Multiple Sclerosis

CT.gov ↗
NCT00203060
Rasagiline Mesylate

Approved completed small_molecule

Parkinson's Disease

CT.gov ↗
NCT00203073
glatiramer acetate 20 mg

Phase 2 completed small_molecule

Relapsing Remitting Multiple Sclerosis

CT.gov ↗
NCT00203099
Glatiramer Acetate, N-Acetylcysteine

Phase 2 completed small_molecule

Relapse Remitting Multiple Sclerosis

CT.gov ↗
NCT00203112
glatiramer acetate with minocycline

Phase 2 completed small_molecule

Relapse Remitting Multiple Sclerosis

CT.gov ↗
NCT00203125
Rasagiline Mesylate

Approved completed small_molecule

Parkinson's Disease

CT.gov ↗
NCT00203138
Rasagiline Mesylate

Approved completed small_molecule

Parkinson's Disease

CT.gov ↗
NCT00203151
edratide

Phase 2 terminated small_molecule

Systemic Lupus Erythematosus

CT.gov ↗
NCT00203164
Rasagiline Mesylate

Approved completed small_molecule

Parkinson's Disease

CT.gov ↗
NCT00203177
Rasagiline Mesylate

Approved completed small_molecule

Parkinson's Disease

CT.gov ↗
NCT00214942
ORAVESCENT Fentanyl Citrate

Phase 3 completed small_molecule

Chronic Low Back Pain

CT.gov ↗
NCT00214955
ORAVESCENT Fentanyl Citrate

Phase 3 completed small_molecule

Chronic Neuropathic Pain

CT.gov ↗
NCT00214968
Modafinil

Phase 3 completed small_molecule

Narcolepsy

CT.gov ↗
NCT00214981
Modafinil

Phase 3 completed small_molecule

Attention Deficit/Hyperactivity Disorder

CT.gov ↗
NCT00214994
Gabitril

Phase 3 completed small_molecule

Anxiety Disorders

CT.gov ↗
NCT00220922
Alcohol Wipes vs. No Alcohol Wipes

Approved completed other

Multiple Sclerosis

CT.gov ↗
NCT00228540
Modafinil

Phase 3 completed small_molecule

ADHD

CT.gov ↗
NCT00228553
Armodafinil 100 to 250 mg/day

Phase 3 completed small_molecule

Excessive Daytime Sleepiness

CT.gov ↗
NCT00228566
Armodafinil

Phase 3 completed small_molecule

Excessive Daytime Sleepiness

CT.gov ↗
NCT00228605
OraVescent Fentanyl

Phase 3 completed small_molecule

Low Back Pain

CT.gov ↗
NCT00232999
Nebulized IVX-0142

Phase 2 completed small_molecule

Asthma

CT.gov ↗
NCT00233675
GABITRIL (tiagabine hydrochloride; CEP-6671)

Phase 3 completed small_molecule

General Anxiety Disorder

CT.gov ↗
NCT00236015
Gabitril

Phase 3 completed small_molecule

Anxiety Disorder

CT.gov ↗
NCT00236041
ACTIQ®

Phase 2 completed small_molecule

Cancer

CT.gov ↗
NCT00236054
Gabitril

Phase 3 completed small_molecule

Generalized Anxiety Disorder

CT.gov ↗
NCT00236067
Gabitril

Phase 3 completed small_molecule

Generalized Anxiety Disorder

CT.gov ↗
NCT00236080
PROVIGIL 200 mg

Phase 3 completed small_molecule

Chronic Shift Work Sleep Disorder

CT.gov ↗
NCT00236093
ACTIQ (Oral Transmucosal Fentanyl Citrate [OTFC])

Phase 2 completed small_molecule

Pain

CT.gov ↗
NCT00236119
CEP-701 20mg

Phase 2 completed small_molecule

Psoriasis

CT.gov ↗
NCT00236145
ACTIQ (Oral transmucosal fentanyl citrate)

Phase 3 completed small_molecule

Breakthrough Pain

CT.gov ↗
NCT00239993
glatiramer acetate

Approved active small_molecule

Multiple Sclerosis

CT.gov ↗
NCT00240006
Shared Solutions® plus MS Center v. Shared Solutions®

Approved completed other

Multiple Sclerosis

CT.gov ↗
NCT00240032
glatiramer acetate injection with oral cetirizine hydrochloride

Approved completed small_molecule

Multiple Sclerosis

CT.gov ↗
NCT00242827
Oral CEP-701

Phase 2 terminated small_molecule

Myeloma

CT.gov ↗
NCT00250302
autologous mesenchymal stem cells implantation

Phase 2 completed other

Tibial Fracture

CT.gov ↗
NCT00250341
Qvar

Approved terminated small_molecule

Asthma

CT.gov ↗
NCT00256204
Rasagiline Mesylate

Approved completed small_molecule

Parkinson's Disease

CT.gov ↗
NCT00267592
Talampanel

Phase 2 terminated small_molecule

Glioblastoma Multiforme

CT.gov ↗
NCT00272935
Cenestin 0.3 mg Tablets

Phase 3 completed small_molecule

Hot Flashes

CT.gov ↗
NCT00285051
inhaled delta-8-THC 300mcg or 600mcg per dose

Phase 2 terminated small_molecule

Cancer

CT.gov ↗
NCT00287157
Sublingual Tizanidine HCl

Phase 1 completed small_molecule

Traumatic Brain Injury

CT.gov ↗
NCT00287170
Delayed Release 6MP or Calcitriol vs. Purinethol

Phase 2 completed small_molecule

Crohn's Disease

CT.gov ↗
NCT00293111
SDX-101 (R-Etodolac)

Phase 2 terminated small_molecule

Multiple Myeloma

CT.gov ↗
NCT00308685
Albuterol

Phase 3 completed small_molecule

Asthma

CT.gov ↗
NCT00315276
Modafinil

Phase 3 completed small_molecule

Attention Deficit/Hyperactivity Disorder

CT.gov ↗
NCT00326625
40 mg glatiramer acetate

Phase 2 completed small_molecule

Amyotrophic Lateral Sclerosis

CT.gov ↗
NCT00337779
Glatiramer Acetate (GA) 40 mg

Phase 3 completed small_molecule

Relapsing Remitting Multiple Sclerosis

CT.gov ↗
NCT00343733
OraVescent Fentanyl

Phase 3 completed small_molecule

Pain

CT.gov ↗
NCT00343811
Modafinil

Phase 3 completed small_molecule

Attention Deficit/Hyperactivity Disorder

CT.gov ↗
NCT00349193
laquinimod 0.3

Phase 2 completed small_molecule

Relapsing Remitting Multiple Sclerosis

CT.gov ↗
NCT00358293
Tizanidine (sublingual or oral)

Phase 2 completed small_molecule

Muscle Spasticity

CT.gov ↗
NCT00359892
Obatoclax mesylate (GX15-070MS)

Phase 2 completed small_molecule

Hodgkin's Lymphoma

CT.gov ↗
NCT00360035
Obatoclax mesylate (GX15-070MS)

Phase 2 completed small_molecule

Myelofibrosis

CT.gov ↗
NCT00361569
DR-2041a

Phase 3 completed small_molecule

Menopause

CT.gov ↗
NCT00362479
DR-1021

Phase 3 completed small_molecule

Contraception

CT.gov ↗
NCT00375219
Omacetaxine mepesuccinate

Phase 2 completed small_molecule

Chronic Myeloid Leukemia

CT.gov ↗
NCT00382408
DR-5001

Phase 3 completed mab

Respiratory Tract Diseases

CT.gov ↗
NCT00387010
Fentanyl Buccal Tablets

Phase 3 terminated small_molecule

Pain

CT.gov ↗
NCT00394771
DR-1031

Phase 2 completed small_molecule

Breakthrough Bleeding

CT.gov ↗
NCT00399477
Rasagiline Mesylate

Approved completed small_molecule

Parkinson's Disease

CT.gov ↗
NCT00402207
extrafine HFA-beclomethasone

Unknown completed small_molecule

Asthma

CT.gov ↗
NCT00405951
Obatoclax mesylate 250 ml

Phase 2 completed small_molecule

Lung Cancer

CT.gov ↗
NCT00407303
Obatoclax mesylate

Phase 2 completed small_molecule

Mantle-Cell Lymphoma

CT.gov ↗
NCT00413114
Obatoclax mesylate (GX15-070MS)

Phase 2 completed small_molecule

Myelodysplastic Syndromes

CT.gov ↗
NCT00427856
Obatoclax mesylate

Phase 2 completed small_molecule

Lymphoma, Follicular

CT.gov ↗
NCT00438178
Obatoclax mesylate (GX15-070MS)

Phase 1 completed small_molecule

Hematological Malignancies

CT.gov ↗
NCT00455260
hGH-ViaDerm™ System (hGH or somatropin)

Phase 1 completed small_molecule

Growth Hormone Deficiency

CT.gov ↗
NCT00457574
GMX1777

Phase 1 terminated small_molecule

Solid Tumors and Lymphomas

CT.gov ↗
NCT00462943
Omacetaxine mepesuccinate

Phase 2 completed small_molecule

Chronic Myeloid Leukemia

CT.gov ↗
NCT00463047
Fentanyl Buccal Tablets Compared With Immediate-Release Oxycodone

Phase 3 completed small_molecule

Chronic Pain

CT.gov ↗
NCT00464958
sublingual tizanidine 12 mg

Phase 2 terminated small_molecule

Spasticity

CT.gov ↗
NCT00469729
StemEx®

Phase 3 completed small_molecule

Hematologic Malignancies

CT.gov ↗
NCT00481195
Armodafinil

Phase 2 completed small_molecule

Bipolar I Depression

CT.gov ↗
NCT00483275
Alfacalcidol

Approved terminated small_molecule

Accidental Falls

CT.gov ↗
NCT00487942
armodafinil

Phase 2 completed small_molecule

Schizophrenia

CT.gov ↗
NCT00509145
Laquinimod

Phase 3 completed small_molecule

Multiple Sclerosis

CT.gov ↗
NCT00513305
Arsenic trioxide

Phase 3 terminated small_molecule

Acute Myeloid Leukemia

CT.gov ↗
NCT00518986
armodafinil

Approved completed small_molecule

Sleep Disorders

CT.gov ↗
NCT00530062
Albuterol-HFA-MDI

Approved completed small_molecule

Asthma

CT.gov ↗
NCT00538434
reslizumab

Phase 3 completed small_molecule

Eosinophilic Esophagitis

CT.gov ↗
NCT00544882
DR-1021

Phase 3 completed small_molecule

Healthy

CT.gov ↗
NCT00546650
Sumatriptan succinate

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00577655
Albuterol

Phase 3 completed small_molecule

Asthma

CT.gov ↗
NCT00586651
lestaurtinib

Phase 2 completed small_molecule

Polycythemia Vera

CT.gov ↗
NCT00587288
Reslizumab

Approved active small_molecule

Asthma

CT.gov ↗
NCT00592839
SCE-B

Approved completed small_molecule

Nocturnal Vasomotor Symptoms

CT.gov ↗
NCT00600964
GX15-070MS

Phase 1 completed small_molecule

Chronic Lymphocytic Leukemia

CT.gov ↗
NCT00605215
Laquinimod

Phase 3 completed small_molecule

Multiple Sclerosis

CT.gov ↗
NCT00615251
DR-2011

Phase 3 completed small_molecule

Infertility

CT.gov ↗
NCT00635089
reslizumab

Phase 3 completed small_molecule

Eosinophilic Esophagitis

CT.gov ↗
NCT00643578
formoterol

Unknown completed small_molecule

Asthma

CT.gov ↗
NCT00665223
ACR16

Phase 3 completed small_molecule

Huntington's Disease

CT.gov ↗
NCT00666224
Glatiramer Acetate (DB)

Phase 3 completed small_molecule

Multiple Sclerosis

CT.gov ↗
NCT00675350
Omacetaxine

Phase 1 completed small_molecule

Hematologic Tumors

CT.gov ↗
NCT00682981
Obatoclax

Phase 2 completed small_molecule

Extensive-stage Small Cell Lung Cancer

CT.gov ↗
NCT00684918
Obatoclax

Phase 2 completed small_molecule

AML

CT.gov ↗
NCT00685113
DR-3001

Phase 3 completed small_molecule

Overactive Bladder

CT.gov ↗
NCT00696332
Talampanel

Phase 2 completed small_molecule

ALS

CT.gov ↗
NCT00711516
Armodafinil

Approved completed small_molecule

Excessive Sleepiness

CT.gov ↗
NCT00712881
Liposomal doxorubicin hydrochloride

Phase 2 completed small_molecule

Breast Cancer

CT.gov ↗
NCT00720018
NP101 Sumatriptan Iontophoretic Transdermal Patch

Phase 3 completed small_molecule

Migraine Disorders

CT.gov ↗
NCT00723983
Sumatriptan succinate

Phase 1 completed small_molecule

Migraine Disorders

CT.gov ↗
NCT00724048
ACR16

Phase 2 completed small_molecule

Huntington Disease

CT.gov ↗
NCT00724815
NP101 Sumatriptan Iontophoretic Transdermal Patch

Phase 3 completed small_molecule

Migraine Disorders

CT.gov ↗
NCT00724841
Obatoclax Mesylate

Phase 2 terminated small_molecule

Metastatic Melanoma

CT.gov ↗
NCT00731172
glatiramer acetate

Phase 2 active small_molecule

Crohns Disease

CT.gov ↗
NCT00737932
Laquinimod

Phase 2 completed small_molecule

Crohn's Disease

CT.gov ↗
NCT00745615
Laquinimod

Phase 3 terminated small_molecule

Relapsing Remitting Multiple Sclerosis

CT.gov ↗
NCT00758498
Armodafinil

Approved completed small_molecule

Excessive Sleepiness

CT.gov ↗
NCT00772005
armodafinil

Phase 2 completed small_molecule

Schizophrenia

CT.gov ↗
NCT00774982
Delayed Release 6 mercaptopurine

Phase 1 completed small_molecule

Crohns Disease

CT.gov ↗
NCT00777556
DR-104

Phase 3 completed small_molecule

Emergency Contraception

CT.gov ↗
NCT00781456
91-day Levonorgestrel Oral Contraceptive

Phase 2 completed small_molecule

Migraine

CT.gov ↗
NCT00782769
Oxybutinyn Vaginal Ring 4mg

Phase 3 completed small_molecule

Overactive Bladder

CT.gov ↗
NCT00792103
NP101

Phase 3 completed small_molecule

Migraine Disorders

CT.gov ↗
NCT00806546
NP101

Phase 3 completed small_molecule

Migraine Disorders

CT.gov ↗
NCT00813488
Fentanyl Buccal Tablet

Phase 3 completed small_molecule

Chronic Pain

CT.gov ↗
NCT00825227
Armodafinil 150 mg/day

Phase 2 terminated small_molecule

Fatigue

CT.gov ↗
NCT00828321
Ramipril 10 mg capsule

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00829309
pravastatin

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00829426
Alprazolam Extended-Release 3 mg Tablets

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00829452
Ramipril 10 mg capsule

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00829504
Ropinirole HCl 0.25 mg Tablets

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00829530
Ramipril 10 mg capsule

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00829673
Dexmethylphenidate Hydrochloride

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00829712
Dexmethylphenidate Hydrochloride

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00829764
Doxycycline Monohydrate

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00829790
Doxycycline Monohydrate

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00829868
Zaleplon 10 mg Capsules

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00829894
Risperidone

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00829998
Zaleplon 10 mg Capsules

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00830024
Alprazolam Extended-Release 3 mg Tablets

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00830154
pagoclone

Phase 3 completed small_molecule

Stuttering

CT.gov ↗
NCT00830206
Zithromax®

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00830219
Ropinirole HCl 0.25 mg Tablets

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00830258
Pravastatin sodium 80 mg tablets

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00830336
Azithromycin

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00830349
Risperidone

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00830414
medroxyprogesterone acetate

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00833521
Zolpidem 10 mg tablets

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00833586
Terbinafine HCl 250mg tablets

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00833664
Terbinafine HCl 250mg tablets

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00833937
Zolpidem 10 mg tablets

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00834067
Moexipril HCl/hydrochlorothiazide 15/25 mg tablets

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00834132
Azithromycin 600 mg Tablet

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00834197
Mirtazapine 15 mg (Orally Disintegrating) Tablets

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00834249
Venlafaxine 25 mg Tablets

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00834275
Cefadroxil 500 mg Capsules

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00834340
Glimepiride 4 mg Tablets

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00834379
pravastatin sodium

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00834405
ARAVA® 20 mg tablets

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00834418
Leflunomide 20 mg Tablets

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00834431
Famciclovir 500 mg Tablets

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00834444
Famciclovir 500 mg Tablets

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00834522
Granisetron hydrochloride 1 mg tablets

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00834535
Cefdinir Capsules 300 mg

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00834561
Lamotrigine

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00834574
Cefdinir for oral suspension 250 mg/5mL

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00834587
5 mg/500 mg METAGLIP™ Tablets

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00834613
Glucophage® XR 750 mg Tablets

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00834639
Divalproex Sodium

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00834717
Granisetron hydrochloride 1 mg tablets

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00834743
Glucophage® XR 750 mg Tablets

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00834756
Azithromycin 600 mg Tablet

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00834795
Carvedilol 25 mg tablets

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00834847
pravastatin

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00834873
Carvedilol 25 mg tablets

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00834964
Venlafaxine 25 mg Tablets

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00834977
Amlodipine-benazepril 10 mg-20 mg capsules

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00834990
Divalproex Sodium

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00835042
Moexipril HCl/hydrochlorothiazide 15/25 mg tablets

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00835081
Cefadroxil 500 mg Capsules

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00835146
Ribavirin 200 mg tablets

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00835172
Glimepiride 4 mg Tablets

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00835211
Desmopressin Acetate 0.2 mg Tablets

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00835263
Lamotrigine

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00835276
Fexofenadine 180 mg tablets

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00835354
Cefprozil for oral suspension 250 mg/5 mL

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00835367
Amlodipine-benazepril 10 mg-20 mg capsules

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00835393
Pantoprazole Sodium 40 mg delayed-release tablets

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00835406
Alendronate Sodium Tablets 70mg

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00835484
Cefdinir Capsules 300 mg

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00835497
5 mg/500 mg Glipizide Metformin Hydrochloride Tablets

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00835536
Ribavirin 200 mg tablets

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00835549
Cefdinir for oral suspension 250 mg/5mL

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00835575
Mirtazapine 15 mg (Orally Disintegrating) Tablets

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00835588
Pantoprazole Sodium 40 mg delayed-release tablets

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00835614
Cefprozil for oral suspension 250 mg/5 mL

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00835640
Fexofenadine 180 mg tablets

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00835666
Finasteride 5 mg tablets

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00835692
Clarithromycin

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00835705
amoxicillin-clavulanic acid

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00835796
Finasteride 5 mg tablets

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00835991
Glyburide/Metformin 5 mg/500 mg Tablets

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00836004
Clindamycin 300 mg capsule

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00836056
Clindamycin 300 mg capsule

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00836472
Glyburide/Metformin 5 mg/500 mg Tablets

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00836537
Benazepril HCl 40 mg Tablets

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00836576
Benazepril HCl 40 mg Tablets

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00836667
Zoloft® 100 mg Tablets

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00836706
Clarithromycin

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00836849
Zoloft® 100 mg Tablets

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00836901
amoxicillin-clavulanic acid

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00837265
Balugrastim

Phase 3 completed mab

Chemotherapy-induced Neutropenia

CT.gov ↗
NCT00838136
Lamotrigine 25 mg Chewable Tablets

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00838279
Lamotrigine 25 mg Chewable Tablets

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00838630
Cilostazol 100 mg tablets

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00839930
Cilostazol 50 mg Tablets

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00840073
Trandolapril 4 mg Tablets

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00840099
600 mg Amoxicillin/42.9 mg Clavulanate Postassium /5 mL

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00840203
Rowasa® 4 gm/60 mL Rectal Enema

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00840216
Clarithromycin ER 500 mg tablets

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00840281
Cefzil® 500 mg tablets

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00840398
BUSPAR® 30 mg Tablet

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00840411
Clarithromycin ER 500 mg tablets

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00840476
Meloxicam 15 mg Tablets

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00840606
BUSPAR® 30 mg Tablet

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00840632
Trandolapril 4 mg Tablets

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00840840
600 mg Amoxicillin/42.9 mg Clavulanate Postassium /5 mL

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00840866
cefprozil

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00840879
Meloxicam 15 mg Tablets

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00841542
Amlodipine Besylate

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00841659
Paroxetine HCl

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00841698
Paroxetine HCl

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00841815
Amlodipine Besylate

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00842829
Fentanyl Buccal Tablet (FBT)

Approved terminated small_molecule

Cancer Pain

CT.gov ↗
NCT00846885
Sumatriptan succinate

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00847405
Sumatriptan succinate

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00849485
Levetiracetam

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00849797
Oxcarbazepine

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00849862
Levetiracetam

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00850174
Oxcarbazepine

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00854360
Beclomethasone dipropionate HFA Nasal Aerosol

Phase 2 completed small_molecule

Seasonal Allergic Rhinitis

CT.gov ↗
NCT00856635
Glatiramer Acetate

Phase 3 completed small_molecule

Optic Neuritis

CT.gov ↗
NCT00859430
Levetiracetam

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00859521
Levetiracetam

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00863850
bendamustine

Phase 1 completed small_molecule

Malignancy

CT.gov ↗
NCT00868361
Talampanel (non-radiolabeled), [14C] Talampanel

Phase 1 terminated small_molecule

Healthy

CT.gov ↗
NCT00875264
CEP-11981 (kinase inhibitor)

Phase 1 completed small_molecule

Cancer

CT.gov ↗
NCT00877006
bendamustine

Phase 3 completed small_molecule

Non-Hodgkin's Lymphoma

CT.gov ↗
NCT00891839
Bendamustine

Phase 2 completed small_molecule

Mantle Cell Lymphoma

CT.gov ↗
NCT00893789
Armodafinil

Phase 3 terminated small_molecule

Traumatic Brain Injury

CT.gov ↗
NCT00904943
Topiramate Capsules, 25 mg

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00905164
Topiramate Capsules, 25 mg

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00905346
Topiramate 25 mg Capsules

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00905567
Topiramate 2 x 25 mg tablet

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00905606
Topiramate Tablets

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00907907
Mycophenolate Mofetil

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00908128
Mycophenolate Mofetil

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00909610
Ursodiol

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00909753
Ursodiol

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00910598
glatiramer acetate

Approved active small_molecule

Multiple Sclerosis

CT.gov ↗
NCT00910663
Mycophenolate Mofetil

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00911274
Mycophenolate Mofetil

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00920595
CEP-9722

Phase 1 completed small_molecule

Solid Tumor

CT.gov ↗
NCT00920855
bendamustine

Phase 2 completed small_molecule

Multiple Myeloma

CT.gov ↗
NCT00924560
91-day Levonorgestrel Oral Contraceptive

Phase 2 completed small_molecule

Bone Mineral Density

CT.gov ↗
NCT00934180
Ondansetron

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00934921
Ondansetron

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00937157
Copaxone

Approved completed small_molecule

Multiple Sclerosis

CT.gov ↗
NCT00947752
Glatiramer Acetate

Approved terminated small_molecule

Relapsing Remitting Multiple Sclerosis

CT.gov ↗
NCT00962936
CT-011

Phase 2 terminated small_molecule

Chronic Hepatitis C

CT.gov ↗
NCT00964730
Talampanel

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00966251
CT-011

Phase 2 terminated small_molecule

Primary Hepatocellular Carcinoma

CT.gov ↗
NCT00972855
Bicalutamide

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00973050
Bicalutamide

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00974012
Divalproex Sodium

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00974441
Divalproex Sodium

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT00977665
rasagiline mesylate

Phase 2 completed small_molecule

Multiple System Atrophy

CT.gov ↗
NCT00982150
Talampanel

Phase 2 terminated small_molecule

Amyotrophic Lateral Sclerosis

CT.gov ↗
NCT00983437
Armodafinil

Phase 3 terminated small_molecule

Traumatic Brain Injury

CT.gov ↗
NCT00988052
Laquinimod

Phase 3 terminated small_molecule

Relapsing Multiple Sclerosis

CT.gov ↗
NCT00988247
Beclomethasone dipropionate

Phase 3 completed small_molecule

Rhinitis, Allergic, Perennial

CT.gov ↗
NCT00988988
AGEE cream

Approved terminated small_molecule

Multiple Sclerosis

CT.gov ↗
NCT00990340
T-jet® containing TevTropin®

Approved completed other

Growth Hormone Deficiency

CT.gov ↗
NCT00991510
mycophenolate mofetil (Myfenax)

Approved terminated small_molecule

Stable Renal Transplant Recipients

CT.gov ↗
NCT00996580
DR-103

Phase 3 completed small_molecule

Pregnancy Prevention

CT.gov ↗
NCT01006655
Beclomethasone dipropionate HFA

Phase 2 completed small_molecule

Asthma

CT.gov ↗
NCT01007630
Rasagiline

Approved active small_molecule

Parkinson's Disease

CT.gov ↗
NCT01020396
Metronidazole

Phase 2 completed small_molecule

Bacterial Vaginosis

CT.gov ↗
NCT01020877
Metronidazole

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT01023880
CEP-18770

Phase 2 terminated small_molecule

Multiple Myeloma

CT.gov ↗
NCT01024608
Beclomethasone dipropionate

Phase 3 completed small_molecule

Seasonal Allergic Rhinitis

CT.gov ↗
NCT01045967
Lansoprazole

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT01046084
Lansoprazole

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT01046214
Bupropion HCl

Phase 1 terminated small_molecule

Depressive Disorder

CT.gov ↗
NCT01046253
Lansoprazole

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT01047319
Laquinimod

Phase 3 terminated small_molecule

Relapsing Multiple Sclerosis

CT.gov ↗
NCT01049984
Rasagiline

Approved active small_molecule

Parkinson's Disease

CT.gov ↗
NCT01055379
Rasagiline

Approved completed small_molecule

Depressive Symptoms

CT.gov ↗
NCT01056159
Albuterol dry powder inhaler

Phase 1 completed small_molecule

Asthma

CT.gov ↗
NCT01058863
Albuterol Spiromax®

Phase 3 completed small_molecule

Asthma

CT.gov ↗
NCT01067521
Glatiramer acetate (GA)

Phase 3 completed small_molecule

Relapsing Remitting Multiple Sclerosis

CT.gov ↗
NCT01072630
Armodafinil

Phase 3 completed small_molecule

Depression

CT.gov ↗
NCT01072929
Armodafinil

Phase 3 completed small_molecule

Depression

CT.gov ↗
NCT01073163
bendamustine

Phase 3 completed small_molecule

Non-Hodgkin's Lymphoma

CT.gov ↗
NCT01074450
Pramipexole Dihydrochloride

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT01074463
Pramipexole Dihydrochloride

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT01080807
Armodafinil

Approved completed small_molecule

Excessive Sleepiness

CT.gov ↗
NCT01083615
custirsen sodium

Phase 3 terminated small_molecule

Castrate-Resistant Prostate Cancer

CT.gov ↗
NCT01085084
Laquinimod

Phase 2 completed small_molecule

Lupus Arthritis

CT.gov ↗
NCT01085097
Laquinimod

Phase 2 completed small_molecule

Lupus Nephritis

CT.gov ↗
NCT01088984
Bendamustine

Phase 2 completed small_molecule

Leukemia

CT.gov ↗
NCT01094613
Delayed Release 6 mercaptopurine

Phase 2 terminated small_molecule

Crohn's Disease

CT.gov ↗
NCT01108341
Bendamustine hydrochloride

Phase 2 completed small_molecule

Non-Hodgkin's Lymphoma (NHL)

CT.gov ↗
NCT01121536
Armodafinil

Phase 3 completed small_molecule

Depression

CT.gov ↗
NCT01123070
RA-TL011-101

Phase 1 completed mab

Rheumatoid Arthritis

CT.gov ↗
NCT01124162
Losartan

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT01124175
Losartan

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT01126190
Neugranin

Phase 3 completed mab

Chemotherapy-induced Neutropenia

CT.gov ↗
NCT01133626
Placebo Nasal Aerosol

Phase 3 completed small_molecule

Perennial Allergic Rhinitis

CT.gov ↗
NCT01134705
Beclomethasone dipropionate hydrofluoroalkane HFA Nasal Aerosol

Phase 3 completed small_molecule

Rhinitis, Allergic, Perennial

CT.gov ↗
NCT01135459
CEP-33457

Phase 3 completed small_molecule

Systemic Lupus Erythematosus

CT.gov ↗
NCT01149460
Valacyclovir

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT01149473
Losartan potassium/Hydrochlorothiazide

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT01149486
Losartan potassium/Hydrochlorothiazide

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT01149499
Valacyclovir

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT01149733
Tamsulosin

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT01149746
Tamsulosin

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT01151787
cyclobenzaprine hydrochloride

Phase 3 terminated small_molecule

Chronic Migraine

CT.gov ↗
NCT01157169
Buprenorphine

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT01157182
Estradiol/Norethindrone acetate

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT01159873
CEP-37251

Phase 1 terminated small_molecule

Bone Loss

CT.gov ↗
NCT01167426
Glatiramer Acetate 20 mg/0.5 mL

Phase 3 completed small_molecule

Multiple Sclerosis

CT.gov ↗
NCT01178125
DR-102

Phase 3 completed small_molecule

Contraception

CT.gov ↗
NCT01181726
Estradiol/Norethindrone acetate

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT01182181
Anastrozole (Teva Pharmaceuticals USA)

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT01182194
Drospirenone/Ethinyl Estradiol (Gianvi®)

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT01182207
Drospirenone/Ethinyl Estradiol (Gianvi®)

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT01182636
Adapalene

Phase 1 completed small_molecule

Acne Vulgaris

CT.gov ↗
NCT01183390
Anastrozole

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT01187888
Rasagiline

Phase 3 terminated small_molecule

Progressive Supranuclear Palsy

CT.gov ↗
NCT01188187
Custirsen

Phase 3 completed small_molecule

Prostate Cancer

CT.gov ↗
NCT01192503
rasagiline

Phase 3 terminated small_molecule

Restless Legs Syndrome

CT.gov ↗
NCT01205737
TL011

Phase 1 completed mab

DLBCL

CT.gov ↗
NCT01218009
Placebo Spiromax

Phase 3 terminated small_molecule

Asthma

CT.gov ↗
NCT01223365
Hydrocodone ER

Phase 3 completed small_molecule

Chronic Pain

CT.gov ↗
NCT01240694
CEP-33457

Phase 3 completed small_molecule

Systemic Lupus Erythematosus

CT.gov ↗
NCT01240863
Hydrocodone ER

Phase 3 completed small_molecule

Chronic Pain

CT.gov ↗
NCT01240876
CEP-37247

Phase 2 completed small_molecule

Sciatica

CT.gov ↗
NCT01247272
Fluoxetine Hydrochloride

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT01247285
Fluoxetine Hydrochloride

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT01252186
91-day Levonorgestrel Oral Contraceptive

Phase 2 completed small_molecule

Hemostasis

CT.gov ↗
NCT01260896
Venlafaxine Hydrochloride

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT01260922
Donepezil Hydrochloride

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT01260948
Donepezil Hydrochloride

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT01265849
LI

Phase 3 completed mab

Squamous Cell Carcinoma of the Oral Cavity

CT.gov ↗
NCT01270464
Reslizumab

Phase 3 completed small_molecule

Eosinophilic Asthma

CT.gov ↗
NCT01282801
Venlafaxine Hydrochloride

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT01282814
Venlafaxine Hydrochloride

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT01285323
Reslizumab

Phase 3 completed small_molecule

Eosinophilic Asthma

CT.gov ↗
NCT01287039
Reslizumab

Phase 3 completed small_molecule

Eosinophilic Asthma

CT.gov ↗
NCT01290887
Reslizumab

Phase 3 completed small_molecule

Eosinophilic Asthma

CT.gov ↗
NCT01291004
Desogestrel/ethinyl estradiol and ethinyl estradiol

Phase 1 completed small_molecule

Follicle Development

CT.gov ↗
NCT01305408
Armodafinil

Phase 3 completed small_molecule

Depression

CT.gov ↗
NCT01307319
BDP HFA

Phase 3 completed small_molecule

Seasonal Allergic Rhinitis

CT.gov ↗
NCT01311713
CEP-9722

Phase 2 terminated small_molecule

Solid Tumors

CT.gov ↗
NCT01319266
Hydrocodone Bitartrate extended-release tablet

Phase 1 completed small_molecule

Renal Impairment

CT.gov ↗
NCT01319279
Hydrocodone bitartrate extended-release tablet

Phase 1 completed small_molecule

Hepatic Impairment

CT.gov ↗
NCT01340625
Norethindrone/Ethinyl Estradiol

Phase 1 completed small_molecule

Bioequivalence

CT.gov ↗
NCT01344369
Norethindrone/Ethinyl Estradiol

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT01345357
CEP-9722

Phase 1 completed small_molecule

Solid Tumors or Mantle Cell Lymphoma

CT.gov ↗
NCT01348919
CEP-18770

Phase 2 terminated small_molecule

Multiple Myeloma

CT.gov ↗
NCT01381796
NP101

Phase 1 completed small_molecule

Compare Bioequivalence Patches Previously Used in the NP101-007 Study

CT.gov ↗
NCT01382342
Rasagiline

Approved active small_molecule

Parkinson's Disease

CT.gov ↗
NCT01388491
desogestrel/ethinyl estradiol and ethinyl estradiol

Phase 2 completed small_molecule

Hemostasis

CT.gov ↗
NCT01396213
Larazotide Acetate

Phase 2 completed small_molecule

Celiac Disease

CT.gov ↗
NCT01397734
Arsenic trioxide

Phase 1 terminated small_molecule

Chronic Myelogenous Leukemia

CT.gov ↗
NCT01404117
Laquinimod 0.6

Phase 2 terminated small_molecule

Relapsing Multiple Sclerosis

CT.gov ↗
NCT01424813
Placebo MDPI

Phase 3 completed small_molecule

Asthma

CT.gov ↗
NCT01426880
Carboplatin

Phase 3 completed small_molecule

Tubular Breast Cancer Stage II

CT.gov ↗
NCT01433432
80 mg DR-6MP

Phase 2 terminated small_molecule

Crohn's Disease

CT.gov ↗
NCT01439230
Donepezil

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT01439243
Donepezil

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT01442610
Rasagiline

Approved completed small_molecule

Sleep Disturbances

CT.gov ↗
NCT01447732
CEP-37250/KHK2804

Phase 1 completed small_molecule

Solid Tumour

CT.gov ↗
NCT01454791
diclofenac sodium topical gel

Approved completed small_molecule

Multiple Sclerosis

CT.gov ↗
NCT01460628
Armodafinil

Approved completed small_molecule

Menopause

CT.gov ↗
NCT01470248
Arsenic Trioxide

Phase 2 completed small_molecule

Lung Cancer

CT.gov ↗
NCT01479621
Fp MDPI

Phase 2 completed small_molecule

Asthma

CT.gov ↗
NCT01497470
Custirsen, paclitaxel and carboplatin

Phase 1 completed small_molecule

Cancer

CT.gov ↗
NCT01497652
Rasagiline/Placebo

Approved completed small_molecule

Parkinson's Disease

CT.gov ↗
NCT01508936
Reslizumab

Phase 3 completed small_molecule

Eosinophilic Asthma

CT.gov ↗
NCT01523236
Mometasone furoate

Phase 2 completed small_molecule

Seasonal Allergic Rhinitis

CT.gov ↗
NCT01537692
BDP HFA Nasal Aerosol

Phase 1 completed small_molecule

Allergic Rhinitis

CT.gov ↗
NCT01563601
Obatoclax Mesylate, Carboplatine and Etoposide

Phase 3 terminated small_molecule

Extensive-stage Small Cell Lung Cancer

CT.gov ↗
NCT01576718
Fp MDPI

Phase 2 completed small_molecule

Asthma

CT.gov ↗
NCT01578785
Glatiramer Acetate

Approved terminated small_molecule

Relapsing Remitting Multiple Sclerosis

CT.gov ↗
NCT01585649
Lipegfilgrastim

Phase 1 completed small_molecule

Ewing Family of Tumors, Rhabdomyosarcoma

CT.gov ↗
NCT01596621
Bendamustine hydrochloride

Phase 3 completed small_molecule

Non-Hodgkin Lymphoma

CT.gov ↗
NCT01596673
45-mg hydrocodone bitartrate extended-release tablet (crushed or intact)

Phase 1 completed small_molecule

Drug Abuse

CT.gov ↗
NCT01624480
Armodafinil

Phase 3 completed small_molecule

Narcolepsy

CT.gov ↗
NCT01686152
Imiquimod Cream, 3.75%

Phase 3 completed small_molecule

Actinic Keratosis

CT.gov ↗
NCT01697956
BDP

Phase 3 completed small_molecule

Allergic Rhinitis

CT.gov ↗
NCT01698320
Placebo MDPI

Phase 3 completed small_molecule

Asthma

CT.gov ↗
NCT01707992
Laquinimod

Phase 3 completed small_molecule

Multiple Sclerosis

CT.gov ↗
NCT01710228
methylprednisolone

Phase 2 terminated small_molecule

Multiple Sclerosis (MS)

CT.gov ↗
NCT01723228
Rasagiline

Approved active small_molecule

Parkinson's Disease

CT.gov ↗
NCT01741285
Beclomethasone (QVAR)

Approved completed small_molecule

Asthma

CT.gov ↗
NCT01747629
Placebo MDPI

Phase 3 completed small_molecule

Asthma

CT.gov ↗
NCT01758978
C33237/1106

Phase 1 completed small_molecule

Pain

CT.gov ↗
NCT01769677
C33237/1099

Phase 1 completed small_molecule

Pain

CT.gov ↗
NCT01772368
Fp MDPI

Phase 2 completed small_molecule

Asthma

CT.gov ↗
NCT01783548
BDP Nasal Aerosol

Phase 3 completed small_molecule

Allergic Rhinitis

CT.gov ↗
NCT01785433
Tiotropium HFA BAI 4.5 mcg

Phase 2 completed small_molecule

COPD

CT.gov ↗
NCT01789970
Hydrocodone ER

Phase 3 completed small_molecule

Low Back Pain

CT.gov ↗
NCT01791972
Albuterol Spiromax

Phase 3 completed small_molecule

Exercise-Induced Bronchoconstriction (EIB)

CT.gov ↗
NCT01795859
SD-809

Phase 3 completed small_molecule

Chorea

CT.gov ↗
NCT01803555
Budesonide/Formoterol SPIROMAX®

Phase 3 completed small_molecule

Asthma

CT.gov ↗
NCT01811576
TV-1106

Phase 3 terminated small_molecule

Growth Hormone-Deficiency

CT.gov ↗
NCT01844401
Albuterol Spiromax®

Phase 3 completed small_molecule

Asthma

CT.gov ↗
NCT01844869
omacetaxine mepesuccinate

Phase 1 completed small_molecule

Hematologic Malignancies

CT.gov ↗
NCT01848652
infusion of MYOCET

Phase 2 terminated small_molecule

Cerebral Lymphoma B Cell Refractory

CT.gov ↗
NCT01856114
Fentanyl Buccal Tablet

Phase 2 completed small_molecule

Advanced Cancers

CT.gov ↗
NCT01857323
Albuterol Spiromax®

Phase 3 completed small_molecule

Asthma

CT.gov ↗
NCT01873495
Omacetaxine

Phase 2 terminated small_molecule

Acute Myelogenous Leukemia (AML)

CT.gov ↗
NCT01874145
GA 20 mg/mL

Phase 3 completed small_molecule

Relapsing-Remitting Multiple Sclerosis

CT.gov ↗
NCT01874561
Custirsen

Phase 1 completed small_molecule

Cardiac Conduction and Repolarization

CT.gov ↗
NCT01879748
Rasagiline

Approved active small_molecule

Parkinson's Disease

CT.gov ↗
NCT01887366
TV-1380 150 mg

Phase 2 completed small_molecule

Cocaine Addiction

CT.gov ↗
NCT01894048
Qvar® (beclometasone dipropionate HFA)

Approved completed small_molecule

Asthma

CT.gov ↗
NCT01896128
Armodafinil

Phase 2 completed small_molecule

Stroke

CT.gov ↗
NCT01897896
SD-809

Phase 3 completed small_molecule

Chorea Associated With Huntington Disease

CT.gov ↗
NCT01899144
Albuterol Spiromax®

Phase 3 completed small_molecule

Asthma

CT.gov ↗
NCT01900509
bendamustine

Phase 2 active small_molecule

Hodgkin Lymphoma

CT.gov ↗
NCT01903824
CEP-26401

Phase 1 completed small_molecule

Cognitive Impairment

CT.gov ↗
NCT01907334
Advair Diskus100/50 µg

Approved completed small_molecule

Asthma

CT.gov ↗
NCT01922739
Hydrocodone ER

Phase 3 completed small_molecule

Low Back Pain

CT.gov ↗
NCT01922752
CEP-37440

Phase 1 completed small_molecule

Solid Tumors

CT.gov ↗
NCT01935492
BOOG 2010-02 Stop&Go study

Phase 3 completed small_molecule

Human Epidermal Growth Factor 2 Negative Carcinoma of Breast

CT.gov ↗
NCT01940601
Balugrastim

Phase 2 terminated small_molecule

Solid Tumors

CT.gov ↗
NCT01975298
Laquinimod

Phase 3 terminated small_molecule

Relapsing Remitting Multiple Sclerosis

CT.gov ↗
NCT01990443
Reslizumab IV

Phase 1 completed small_molecule

Absolute Bioavailability

CT.gov ↗
NCT01991509
LBR-101 IV

Phase 1 completed mab

Bioavailability and Pharmacokinetics

CT.gov ↗
NCT02021773
LBR-101 High Dose

Phase 2 completed small_molecule

Chronic Migraine

CT.gov ↗
NCT02025556
LBR-101 High Dose

Phase 2 completed small_molecule

Episodic Migraine Headache

CT.gov ↗
NCT02029417
cytarabine

Phase 2 terminated small_molecule

Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome

CT.gov ↗
NCT02030457
Beclomethasone dipropionate BAI

Phase 1 completed small_molecule

Pharmacokinetics

CT.gov ↗
NCT02031640
Beclomethasone dipropionate

Phase 3 completed small_molecule

Asthma

CT.gov ↗
NCT02040766
Beclomethasone dipropionate BAI

Phase 3 completed small_molecule

Asthma

CT.gov ↗
NCT02040779
Beclomethasone dipropionate breath-actuated inhaler

Phase 3 completed small_molecule

Persistent Asthma

CT.gov ↗
NCT02044276
lipegfilgrastim

Phase 3 completed small_molecule

Aggressive B Cell Non-Hodgkin Lymphomas at High Risk for R-CHOP-21-induced Neutropenia

CT.gov ↗
NCT02062463
Budesonide and formoterol fumarate dehydrate (BF) SPIROMAX

Phase 3 completed small_molecule

Asthma

CT.gov ↗
NCT02068599
TV-45070

Phase 2 completed small_molecule

Osteoarthritis of the Knee

CT.gov ↗
NCT02078960
Omacetaxine mepesuccinate

Phase 2 completed small_molecule

Chronic Myeloid Leukemia

CT.gov ↗
NCT02085863
laquinimod

Phase 1 completed small_molecule

Pharmacokinetics

CT.gov ↗
NCT02092077
TV-1106

Phase 3 terminated small_molecule

Growth Hormone-Deficiency

CT.gov ↗
NCT02092571
Progesterone vaginal ring,

Phase 1 completed small_molecule

Pharmacokinetics

CT.gov ↗
NCT02125344
non-pegylated liposomal doxorubicin

Phase 3 completed small_molecule

Tubular Breast Cancer Stage II

CT.gov ↗
NCT02126839
Albuterol MDPI

Phase 3 completed small_molecule

Asthma

CT.gov ↗
NCT02139644
FS MDPI

Phase 3 completed small_molecule

Asthma

CT.gov ↗
NCT02141477
Omacetaxine

Phase 2 terminated small_molecule

Leukemia

CT.gov ↗
NCT02141854
FS MDPI

Phase 3 completed small_molecule

Asthma

CT.gov ↗
NCT02159872
Omacetaxine

Phase 2 terminated small_molecule

Leukemia

CT.gov ↗
NCT02175771
Fp MDPI

Phase 3 completed small_molecule

Persistent Asthma

CT.gov ↗
NCT02184767
ADASUVE®

Phase 1 completed small_molecule

BiPolar

CT.gov ↗
NCT02190695
Decitabine

Phase 2 completed small_molecule

Acute Myeloid Leukemia

CT.gov ↗
NCT02190721
tbo-filgrastim

Phase 2 completed small_molecule

Neutropenia

CT.gov ↗
NCT02195700
SD-809

Phase 3 completed small_molecule

Tardive Dyskinesia

CT.gov ↗
NCT02198794
SD-809

Phase 3 completed small_molecule

Tardive Dyskinesia

CT.gov ↗
NCT02202005
Nevirapine

Phase 1 completed small_molecule

HIV-1

CT.gov ↗
NCT02203474
Tiotropium HFA BAI 5 mcg

Phase 2 terminated small_molecule

Chronic Obstructive Pulmonary Disease

CT.gov ↗
NCT02207387
Azilect

Unknown active small_molecule

Parkinson's Disease

CT.gov ↗
NCT02214381
Myocet

Phase 3 completed small_molecule

Early Primary Breast Cancer

CT.gov ↗
NCT02215616
Laquinimod

Phase 2 completed small_molecule

Huntington's Disease

CT.gov ↗
NCT02215941
TV-45070

Phase 1 completed small_molecule

Pharmacokinetics

CT.gov ↗
NCT02246920
Fluticasone propionate

Phase 3 terminated small_molecule

Seasonal Allergic Rhinitis

CT.gov ↗
NCT02249663
Azelastine hydrochloride and Fluticasone propionate

Phase 3 active small_molecule

Seasonal Allergic Rhinitis

CT.gov ↗
NCT02284568
Placebo

Phase 2 completed small_molecule

Primary Progressive Multiple Sclerosis

CT.gov ↗
NCT02291861
SD-809

Phase 3 completed small_molecule

Tardive Dyskinesia

CT.gov ↗
NCT02306915
lipegfilgrastim

Phase 1 completed small_molecule

Pharmacokinetics

CT.gov ↗
NCT02311764
Carboplatin

Phase 2 terminated small_molecule

Prostatic Neoplasm

CT.gov ↗
NCT02315131
TV46017

Phase 1 terminated small_molecule

Chronic Obstructive Pulmonary Disease (COPD

CT.gov ↗
NCT02315144
TV48108

Phase 1 terminated small_molecule

Chronic Obstructive Pulmonary Disease

CT.gov ↗
NCT02365636
TV-45070

Phase 2 completed small_molecule

Postherpetic Neuralgia

CT.gov ↗
NCT02410343
TV-1106

Phase 3 terminated small_molecule

Growth Hormone-Deficiency

CT.gov ↗
NCT02410356
TV-1106

Phase 3 terminated small_molecule

Growth Hormone-Deficiency

CT.gov ↗
NCT02416206
BeEAM

Phase 2 completed small_molecule

Multiple Myeloma

CT.gov ↗
NCT02437604
Treatment A: Fp MDPI

Phase 1 completed small_molecule

Asthma

CT.gov ↗
NCT02440568
Cytarabine

Phase 2 terminated small_molecule

Acute Myeloid Leukemia

CT.gov ↗
NCT02452190
Reslizumab

Approved active small_molecule

Asthma

CT.gov ↗
NCT02487108
TV-46763

Phase 3 completed small_molecule

Pain

CT.gov ↗
NCT02495168
Generic Budesonide/Formoterol Fumarate Dihydrate

Phase 3 completed small_molecule

Asthma

CT.gov ↗
NCT02499900
Copaxone

Approved completed small_molecule

Multiple Sclerosis

CT.gov ↗
NCT02501629
Reslizumab

Approved active small_molecule

Asthma

CT.gov ↗
NCT02513160
Beclomethasone Dipropionate 640

Phase 3 completed small_molecule

Persistent Asthma

CT.gov ↗
NCT02519231
Naproxen

Approved completed small_molecule

Menorrhagia

CT.gov ↗
NCT02552303
Armodafinil

Unknown completed small_molecule

Sleep Apnea

CT.gov ↗
NCT02559791
Reslizumab

Phase 3 completed mab

Severe Persistent Asthma

CT.gov ↗
NCT02592031
XM17

Phase 1 completed small_molecule

Bioequivalence

CT.gov ↗
NCT02611804
Diclofenac sodium

Phase 3 completed small_molecule

Actinic Keratosis

CT.gov ↗
NCT02621931
Fremanezumab

Approved active small_molecule

Migraine

CT.gov ↗
NCT02629861
Fremanezumab

Approved active small_molecule

Migraine

CT.gov ↗
NCT02638103
Fremanezumab

Approved active small_molecule

Migraine

CT.gov ↗
NCT02673567
TEV-48125 - 1

Phase 1 completed small_molecule

Pharmacokinetics

CT.gov ↗
NCT02674321
SD-809

Phase 1 completed small_molecule

TOURETTE SYNDROME

CT.gov ↗
NCT02680561
Fluticasone Propionate MDPI

Phase 1 completed small_molecule

Asthma

CT.gov ↗
NCT02684409
PROT-CL-NP101-015.01

Phase 1 completed small_molecule

Acute Migraine

CT.gov ↗
NCT02688140
Arsenic trioxide

Phase 3 completed small_molecule

Acute Promyelocytic Leukemia

CT.gov ↗
NCT02769091
TEV-45478

Phase 2 terminated small_molecule

Nonalcoholic Steatohepatitis

CT.gov ↗
NCT02772211
Ketamine

Approved active small_molecule

Treatment Resistant Depression

CT.gov ↗
NCT02805842
Tacrolimus BID

Phase 3 active small_molecule

Medication Adherence

CT.gov ↗
NCT02817464
TV-46046 - 400 mg/mL

Phase 1 completed small_molecule

Pregnancy

CT.gov ↗
NCT02835794
Omacetaxine

Phase 2 terminated small_molecule

Myelodysplastic Syndromes

CT.gov ↗
NCT02867917
Volcolon sugar free

Unknown completed small_molecule

Constipation

CT.gov ↗
NCT02937168
Reslizumab

Approved active small_molecule

Asthma

CT.gov ↗
NCT02945046
Fremanezumab

Phase 3 terminated small_molecule

Episodic Cluster Headache

CT.gov ↗
NCT02947945
Reslizumab

Approved active small_molecule

Asthma

CT.gov ↗
NCT02964338
Fremanezumab

Phase 3 terminated small_molecule

Chronic Cluster Headache

CT.gov ↗
NCT02969408
Albuterol Sulfate

Phase 3 completed small_molecule

Asthma

CT.gov ↗
NCT02980133
Fluticasone Propionate

Phase 3 completed small_molecule

Asthma

CT.gov ↗
NCT03029000
Tbo-filgrastim

Phase 3 terminated small_molecule

Healthy Participants

CT.gov ↗
NCT03052725
reslizumab

Phase 3 terminated small_molecule

Eosinophils, Asthma

CT.gov ↗
NCT03074942
Reslizumab

Phase 2 completed small_molecule

Severe Asthma

CT.gov ↗
NCT03107052
Fremanezumab

Phase 3 terminated small_molecule

Cluster Headache

CT.gov ↗
NCT03215030
Modakafusp alfa

Phase 2 terminated small_molecule

Multiple Myeloma

CT.gov ↗
NCT03256695
Albuterol sulfate (ABS)

Phase 3 completed small_molecule

Chronic Obstructive Pulmonary Disease

CT.gov ↗
NCT03294538
Generic Estradiol Vaginal Cream USP, 0.01%

Phase 3 completed small_molecule

Atrophic Vaginitis

CT.gov ↗
NCT03301649
Generic Ivermectin Lotion 0.5%

Phase 3 completed small_molecule

Head Lice

CT.gov ↗
NCT03308968
Fremanezumab

Phase 3 completed small_molecule

Migraine Prophylaxis

CT.gov ↗
NCT03347188
Fremanezumab

Phase 2 completed small_molecule

Post-Traumatic Headache

CT.gov ↗
NCT03452943
TEV-50717

Phase 3 terminated small_molecule

Tourette Syndrome

CT.gov ↗
NCT03503318
TV-46000

Phase 3 completed small_molecule

Schizophrenia

CT.gov ↗
NCT03524235
CD56-Enriched Donor Lymphocyte Infusion

Phase 1 completed mab

Multiple Myeloma

CT.gov ↗
NCT03567291
TEV-50717

Phase 3 terminated small_molecule

Tourette Syndrome

CT.gov ↗
NCT03571256
TEV-50717

Phase 3 terminated small_molecule

Tourette Syndrome

CT.gov ↗
NCT03700658
TV-46046

Phase 1 completed small_molecule

Contraception

CT.gov ↗
NCT03755804
bendamustine

Phase 2 active small_molecule

Hodgkin Lymphoma

CT.gov ↗
NCT03756883
Fluticasone Propionate and Salmeterol Inhalation Powder

Phase 3 completed small_molecule

Asthma

CT.gov ↗
NCT03783429
Digoxin

Approved completed small_molecule

Heart Failure

CT.gov ↗
NCT03813238
TEV-50717

Phase 3 terminated small_molecule

Cerebral Palsy, Dyskinetic

CT.gov ↗
NCT03879837
Fluticasone propionate pressurized metered dose inhaler

Phase 3 completed small_molecule

Asthma

CT.gov ↗
NCT03890666
Albuterol eMDPI DS

Approved completed small_molecule

Asthma

CT.gov ↗
NCT03893825
TV-46000

Phase 3 completed small_molecule

Schizophrenia

CT.gov ↗
NCT03954444
Oxymetazoline Hydrochloride

Phase 3 completed small_molecule

Rosacea

CT.gov ↗
NCT03965091
Fremanezumab

Phase 2 terminated small_molecule

Fibromyalgia

CT.gov ↗
NCT04041284
Fremanezumab

Approved active small_molecule

Migraine

CT.gov ↗
NCT04088266
16 mg buprenorphine with 4 mg naloxone sublingual film

Approved terminated other

Evaluation of QTc Interval

CT.gov ↗
NCT04157517
Modakafusp Alfa

Phase 2 terminated small_molecule

Neoplasms

CT.gov ↗
NCT04173260
Deutetrabenazine 6 MG

Phase 2 completed small_molecule

Dystonia, Primary

CT.gov ↗
NCT04200352
TEV-50717

Phase 3 terminated small_molecule

Cerebral Palsy, Dyskinetic

CT.gov ↗
NCT04358068
Hydroxychloroquine (HCQ)

Phase 2 terminated small_molecule

COVID-19

CT.gov ↗
NCT04392648
TAK-573

Phase 1 terminated small_molecule

Relapsed and/or Refractory Multiple Myeloma

CT.gov ↗
NCT04447729
fremanezumab

Phase 2 terminated small_molecule

Interstitial Cystitis

CT.gov ↗
NCT04458857
Fremanezumab

Approved active small_molecule

Migraine

CT.gov ↗
NCT04464707
Fremanezumab

Approved active small_molecule

Migraine

CT.gov ↗
NCT04530110
Fremanezumab

Approved active small_molecule

Migraine

CT.gov ↗
NCT04545385
TEV-48574

Phase 2 terminated small_molecule

Asthma

CT.gov ↗
NCT04635852
Fentanyl

Phase 2 completed small_molecule

Cancer

CT.gov ↗
NCT04677959
Fluticasone propionate/salmeterol (FS)

Approved completed small_molecule

Asthma

CT.gov ↗
NCT04682353
TV-46046

Phase 1 completed small_molecule

Contraception

CT.gov ↗
NCT04693533
Fremanezumab Prefilled Syringe [Ajovy]

Approved terminated small_molecule

Migraine Disorders

CT.gov ↗
NCT04710134
Reslizumab

Approved completed mab

Asthma; Eosinophilic

CT.gov ↗
NCT04713982
Deutetrabenazine

Phase 3 active small_molecule

Huntington Disease

CT.gov ↗
NCT04729621
TVB-009

Phase 3 completed other

Osteoporosis, Postmenopausal

CT.gov ↗
NCT04847674
TEV-53275 Dose A

Phase 2 terminated small_molecule

Asthma

CT.gov ↗
NCT04976192
TEV-45779

Phase 3 completed other

Chronic Urticaria

CT.gov ↗
NCT04997304
AirDuo Digihaler

Approved completed other

Asthma

CT.gov ↗
NCT05241288
Albuterol eMDPI DS

Unknown completed other

Pulmonary Disease, Chronic Obstructive

CT.gov ↗
NCT05458011
Fremanezumab

Approved active small_molecule

Migraine

CT.gov ↗
NCT05499130
TEV-48574

Phase 2 completed small_molecule

Crohn Disease

CT.gov ↗
NCT05532358
anle138b (TEV-56286)

Phase 1 completed small_molecule

Healthy Volunteers

CT.gov ↗
NCT05550337
Trifarotene 0.005 % Topical Cream

Phase 3 completed small_molecule

Acne Vulgaris

CT.gov ↗
NCT05556616
Modakafusp alfa

Phase 2 terminated small_molecule

Multiple Myeloma

CT.gov ↗
NCT05590377
Modakafusp alfa

Phase 2 terminated small_molecule

Multiple Myeloma

CT.gov ↗
NCT05617820
Estradiol

Phase 3 completed small_molecule

Dyspareunia

CT.gov ↗
NCT05668013
TEV-48574 Dose Regimen A

Phase 2 active small_molecule

Crohn Disease

CT.gov ↗
NCT05693935
TV-44749

Phase 3 completed small_molecule

Schizophrenia

CT.gov ↗
NCT05831566
Budesonide/Formoterol fumarate dihydrate

Phase 3 active small_molecule

Asthma

CT.gov ↗
NCT06052267
TEV-56248

Phase 3 active small_molecule

Asthma

CT.gov ↗
NCT06173661
Fremanezumab

Approved active small_molecule

Migraine

CT.gov ↗
NCT06253546
TV-44749

Phase 3 completed small_molecule

Schizophrenia

CT.gov ↗
NCT06290102
TEV-56248

Phase 3 active small_molecule

Asthma

CT.gov ↗
NCT06315283
TV-44749

Phase 3 completed small_molecule

Schizophrenia

CT.gov ↗
NCT06319170
Olanzapine Extended Release

Phase 1 completed small_molecule

Schizophrenia, Schizoaffective Disorder

CT.gov ↗
NCT06365788
Abemaciclib

Phase 2 active small_molecule

Triple Negative Breast Neoplasms

CT.gov ↗
NCT06480552
TEV-56278

Phase 1 active small_molecule

Advanced Solid Tumors

CT.gov ↗
NCT06568237
TEV-56286

Phase 2 active small_molecule

Multiple System Atrophy

CT.gov ↗
NCT06625177
TEV-53408

Phase 1 active small_molecule

Vitiligo

CT.gov ↗
NCT06627231
TEV-56286

Phase 1 completed small_molecule

Healthy Participants

CT.gov ↗
NCT06664619
Fp/ABS

Phase 3 active small_molecule

Asthma

CT.gov ↗
NCT06742957
Tapinarof Cream 1%

Phase 3 completed small_molecule

Plaque Type Psorisis

CT.gov ↗
NCT06807463
TEV-53408

Phase 2 active small_molecule

Celiac Disease

CT.gov ↗
NCT06911567
TEV-56286 Test

Phase 1 completed small_molecule

Healthy Participants

CT.gov ↗
NCT06997198
Deutetrabenazine Oral Capsule

Approved active small_molecule

Tardive Dyskinesia

CT.gov ↗
NCT07184931
Duvakitug

Phase 3 active small_molecule

Crohn's Disease

CT.gov ↗
NCT07184944
Duvakitug

Phase 3 active small_molecule

Crohn's Disease

CT.gov ↗
NCT07184996
Duvakitug

Phase 3 active small_molecule

Ulcerative Colitis

CT.gov ↗
NCT07185009
Duvakitug

Phase 3 active small_molecule

Ulcerative Colitis

CT.gov ↗
NCT07197866
TEV-56286

Phase 2 active small_molecule

Multiple System Atrophy

CT.gov ↗
NCT07601516
Deutetrabenazine

Approved completed small_molecule

Huntington's Disease

CT.gov ↗